Table 1.
Baseline Sociodemographic and Clinical Characteristics
| Characteristic | Total (N=117) | CPM Interest (Before Visit)
|
||
|---|---|---|---|---|
| Not at all to a little (N=59) | Moderate to Extremely (N = 58) | P | ||
| Age (years) [mean (range)] | 54.1 (24–78) | 55.5 (24–78) | 52.5 (28–71) | 0.124 |
| Ethnicity | ||||
| Caucasian/White | 79 (67%) | 36 (61%) | 43 (74%) | 0.039 |
| Hispanic/Latino | 16 (14%) | 6 (10%) | 10 (17%) | |
| African American/Black | 17 (15%) | 13 (22%) | 4 (7%) | |
| Asian/Pacific Islander | 5 (4%) | 4 (7%) | 1 (2%) | |
| Marital status | ||||
| Married/Living with Partner | 86 (74%) | 40 (68%) | 46 (81%) | 0.112 |
| Single/Divorced/Living Alone | 30 (26%) | 19 (32%) | 11 (19%) | |
| Educational level | ||||
| Less than high school | 1 (1%) | 0 (0%) | 1 (2%) | 0.929 |
| High school graduate | 56 (49%) | 28 (47%) | 28 (50%) | |
| College graduate | 45 (39%) | 24 (41%) | 21 (37%) | |
| Graduate/professional degree | 13 (11%) | 7 (12%) | 6 (11%) | |
| Employment status | ||||
| Employed full- or part-time | 68 (58%) | 33 (56%) | 35 (61%) | 0.105 |
| Unemployed | 32 (27%) | 14 (24%) | 18 (32%) | |
| Retired | 16 (14%) | 12 (20%) | 4 (7%) | |
| Stage of disease | ||||
| 0 | 21 (18%) | 10 (17%) | 11 (19%) | 0.987 |
| I | 30 (26%) | 15 (26%) | 15 (26%) | |
| II | 42 (36%) | 22 (37%) | 20 (34%) | |
| III | 24 (20%) | 12 (20%) | 12 (21%) | |
| Histology | ||||
| DCIS | 20 (17%) | 10 (17%) | 10 (17%) | 0.947 |
| Invasive ductal | 83 (71%) | 41 (70%) | 42 (73%) | |
| Invasive lobular | 10 (9%) | 6 (10%) | 4 (7%) | |
| Invasive tubular/mucinous | 4 (3%) | 2 (3%) | 2 (3%) | |
| ER/PR status | ||||
| Negative | 24 (20%) | 13 (22%) | 11 (19%) | 0.681 |
| Positive | 93 (80%) | 46 (78%) | 47 (81%) | |
| HERr2neu status | ||||
| Negative | 46 (39%) | 23 (39%) | 23 (40%) | 0.200 |
| Positive | 12 (11%) | 9 (15%) | 3 (5%) | |
| Unknown | 59 (50%) | 27 (46%) | 32 (55%) | |
| Surgery type | ||||
| Segmental mastectomy | 57 (49%) | 32 (54%) | 25(43%) | 0.045 |
| Unilateral mastectomy | 48 (41%) | 25 (42%) | 23(40%) | |
| CPM | 12 (10%) | 2 (4%) | 10(17%) | |
| Neoadjuvant chemotherapy | ||||
| Yes | 41 (35%) | 18 (30%) | 23 (40%) | 0.300 |
| No | 76 (65%) | 41 (70%) | 35(60%) | |
| Adjuvant chemotherapy | ||||
| Yes | 92 (79%) | 44 (76%) | 48 (83%) | 0.359 |
| No | 24 (21%) | 14 (24%) | 10 (17%) | |
| Adjuvant radiation | ||||
| Yes | 74 (65%) | 39 (68%) | 35 (61%) | 0.433 |
| No | 40 (35%) | 18 (32%) | 22 (39%) | |
Note: Some totals may not equal 100% due to missing data on individual items